Adverse Events Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module

Ignite Creation Date: 2025-12-24 @ 10:38 PM
Ignite Modification Date: 2025-12-25 @ 8:09 PM
NCT ID: NCT00094835
Description: The table of Other Adverse Events summarizes non-serious occurrences of adverse events that exceeded a 5% frequency in any treatment arm.
Frequency Threshold: 5
Time Frame: First dose through 30 days after last dose; maximum time on treatment was 322 days.
Study: NCT00094835
Study Brief: Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Paclitaxel/Carboplatin + Motesanib 50 mg QD Chemotherapy naïve participants received paclitaxel 200 mg/m\^2 and carboplatin chemotherapy administered by intravenous (IV) infusion on Day 1 of each 21-day cycle, and motesanib, 50 mg once daily (QD) orally self-administered on Days 3-21 of Cycle 1 and then on Days 1 to 21 of Cycle 2 and all cycles thereafter. None None 5 6 6 6 View
Paclitaxel/Carboplatin + Motesanib 75 mg BID Chemotherapy naïve participants received paclitaxel 200 mg/m\^2 and carboplatin chemotherapy administered by intravenous (IV) infusion on Day 1 of each 21-day cycle, and motesanib, 75 mg twice daily (BID) orally self-administered on Days 3-21 of Cycle 1 and then on Days 1 to 21 of Cycle 2 and all cycles thereafter. None None 3 6 6 6 View
Panitumumab + Motesanib 125 mg QD Participants with no more than one prior chemotherapy regimen for NSCLC received panitumumab 9.0 mg/kg IV on Day 1 of each 21-day cycle, and motesanib 125 mg QD, orally self-administered on Days 3-21 of Cycle 1 and then on Days 1 to 21 of Cycle 2 and all cycles thereafter. None None 1 7 7 7 View
Panitumumab + Motesanib 75 mg BID Participants with no more than one prior chemotherapy regimen for NSCLC received panitumumab 9.0 mg/kg IV on Day 1 of each 21-day cycle, and motesanib 75 mg BID, orally self-administered on Days 3-21 of Cycle 1 and then on Days 1 to 21 of Cycle 2 and all cycles thereafter. None None 4 5 5 5 View
Panitumumab + Paclitaxel/Carboplatin + Motesanib 125 mg QD Chemotherapy naïve participants received panitumumab 9.0 mg/kg, paclitaxel 200 mg/m\^2 and carboplatin chemotherapy administered by IV infusion on Day 1 of each 21-day cycle, and motesanib 125 mg QD, orally on Days 3-21 of Cycle 1 and then on Days 1 to 21 of Cycle 2 and all cycles thereafter. None None 2 6 6 6 View
Paclitaxel/Carboplatin + Motesanib 125 mg QD Chemotherapy naïve participants received paclitaxel 200 mg/m\^2 and carboplatin chemotherapy administered by intravenous (IV) infusion on Day 1 of each 21-day cycle, and motesanib, 125 mg QD orally self-administered on Days 3-21 of Cycle 1 and then on Days 1 to 21 of Cycle 2 and all cycles thereafter. None None 2 11 11 11 View
Panitumumab + Motesanib 50 mg QD Participants with no more than one prior chemotherapy regimen for NSCLC received panitumumab 9.0 mg/kg IV on Day 1 of each 21-day cycle, and motesanib 50 mg QD, orally self-administered on Days 3-21 of Cycle 1 and then on Days 1 to 21 of Cycle 2 and all cycles thereafter. None None 0 4 4 4 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Dyspnoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Dyspnoea exacerbated SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Hypoxia SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Interstitial lung disease SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Pulmonary embolism SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Hypotension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 9.0 View
Orthostatic hypotension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 9.0 View
Gastrointestinal haemorrhage SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Pancreatitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Non-cardiac chest pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Cholecystitis SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA 9.0 View
Anaemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 9.0 View
Febrile neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 9.0 View
Pancytopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 9.0 View
Atrial fibrillation SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 9.0 View
Adrenal insufficiency SYSTEMATIC_ASSESSMENT Endocrine disorders MedDRA 9.0 View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Staphylococcal sepsis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Urinary tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Femur fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 9.0 View
Anorexia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 9.0 View
Dehydration SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 9.0 View
Hypovolaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 9.0 View
Metastases to central nervous system SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA 9.0 View
Non-small cell lung cancer SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA 9.0 View
Cognitive disorder SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Encephalopathy SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Vocal cord paralysis SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Confusional state SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Mental status changes SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Renal failure acute SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 9.0 View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Leukopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 9.0 View
Neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 9.0 View
Dry eye SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 9.0 View
Vision blurred SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 9.0 View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Chest discomfort SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Cystitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Tooth abscess SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Hypokalaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 9.0 View
Hypomagnesaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 9.0 View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Dysarthria SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Bladder pain SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 9.0 View
Anaemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 9.0 View
Thrombocytopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 9.0 View
Atrial fibrillation SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 9.0 View
Conduction disorder SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 9.0 View
Sinus tachycardia SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 9.0 View
Tachycardia SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 9.0 View
Deafness SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders MedDRA 9.0 View
Ear discomfort SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders MedDRA 9.0 View
Conjunctivitis SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 9.0 View
Diplopia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 9.0 View
Abdominal discomfort SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Abdominal distension SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Abdominal pain lower SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Abdominal pain upper SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Ascites SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Change of bowel habit SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Chapped lips SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Colitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Dysphagia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Flatulence SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Gastrointestinal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Gastrooesophageal reflux disease SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Gingival pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Gingival ulceration SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Hyperchlorhydria SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Inguinal hernia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Mouth ulceration SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Odynophagia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Oesophagitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Oral pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Stomatitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Adverse drug reaction SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Chest pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Chills SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Early satiety SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Hypothermia SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Infusion site pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Irritability SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Localised oedema SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Mucosal inflammation SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Non-cardiac chest pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Oedema SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Oedema peripheral SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Temperature intolerance SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Cholecystitis SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA 9.0 View
Hypersensitivity SYSTEMATIC_ASSESSMENT Immune system disorders MedDRA 9.0 View
Candidiasis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Escherichia bacteraemia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Eye infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Folliculitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Fungal infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Gastroenteritis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Herpes simplex SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Infected cyst SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Liver abscess SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Lymph gland infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Oral candidiasis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Oral infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Paronychia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Rhinitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Sinusitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Staphylococcal infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Subcutaneous abscess SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Tooth infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Urinary tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Incision site complication SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 9.0 View
Blood creatinine increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 9.0 View
Breath sounds abnormal SYSTEMATIC_ASSESSMENT Investigations MedDRA 9.0 View
Haemoglobin decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 9.0 View
Weight decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 9.0 View
White blood cell count decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 9.0 View
Anorexia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 9.0 View
Decreased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 9.0 View
Dehydration SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 9.0 View
Hypercalcaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 9.0 View
Hyperkalaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 9.0 View
Hypoalbuminaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 9.0 View
Hypocalcaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 9.0 View
Hyponatraemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 9.0 View
Hypophosphataemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 9.0 View
Arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 9.0 View
Back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 9.0 View
Muscle spasms SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 9.0 View
Muscular weakness SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 9.0 View
Musculoskeletal chest pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 9.0 View
Musculoskeletal pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 9.0 View
Myalgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 9.0 View
Neck pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 9.0 View
Pain in extremity SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 9.0 View
Shoulder pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 9.0 View
Metastases to central nervous system SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA 9.0 View
Balance disorder SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Cognitive disorder SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Coordination abnormal SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Dysgeusia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Hypoaesthesia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Memory impairment SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Mental impairment SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Neuropathy SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Neuropathy peripheral SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Paraesthesia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Peripheral sensory neuropathy SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Restless legs syndrome SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Speech disorder SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Tremor SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Anxiety SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Confusional state SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Depression SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Mental status changes SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Personality change SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Haematuria SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 9.0 View
Haemorrhage urinary tract SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 9.0 View
Incontinence SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 9.0 View
Micturition urgency SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 9.0 View
Pollakiuria SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 9.0 View
Proteinuria SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 9.0 View
Pelvic discomfort SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA 9.0 View
Allergic cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Dysphonia SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Dyspnoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Dyspnoea exacerbated SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Epistaxis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Haemoptysis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Hiccups SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Hypoxia SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Pharyngolaryngeal pain SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Pleural rub SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Pleuritic pain SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Pulmonary embolism SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Pulmonary haemorrhage SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Rales SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Rhinitis allergic SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Rhinorrhoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Sinus congestion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 9.0 View
Acne SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Alopecia SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Dermatitis SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Dermatitis acneiform SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Dry skin SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Erythema SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Exfoliative rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Hyperhidrosis SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Nail disorder SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Night sweats SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Pain of skin SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Palmar erythema SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Pruritus SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Rash erythematous SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Rash follicular SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Rash generalised SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Rash maculo-papular SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Rash pruritic SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Skin fissures SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Skin lesion SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Skin ulcer SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Deep vein thrombosis SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 9.0 View
Flushing SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 9.0 View
Hot flush SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 9.0 View
Hypertension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 9.0 View
Hypotension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 9.0 View
Orthostatic hypotension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 9.0 View
Phlebitis SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 9.0 View
Thrombosis SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 9.0 View